Lab Incorporate Sophia Genetics’ Tech to Detect HRD in Ovarian Cancer
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Cancer |
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read MorePosted by Andy Lundin | Apr 15, 2024 | Womens Health |
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Chris Wolski | Apr 11, 2024 | Lab Management |
XiFin has published the reimbursement rates for key pathology and molecular tests, giving key data for benchmarking.
Read MorePosted by Andy Lundin | Apr 9, 2024 | Compliance |
ADLM released the results of a survey the organization conducted to determine how the FDA’s proposed LDT rule would impact patient care.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Diagnostic Technologies |
The new diagnostic tool combines optofluidics and nanopore technology to create a lab-on-a-chip diagnostic system.
Read More